ArticleCells2020

The E2F Pathway Score as a Predictive Biomarker of Response to Neoadjuvant Therapy in ER+/HER2- Breast Cancer.

Masanori Oshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.